Back

Atheroprotective effects of ticagrelor, a P2Y12 antagonist, in apolipoprotein-E-deficient mice

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Inflammation and microcirculation Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Byambasuren Ganbaatar

Institute of Health Biosciences- The University of Tokushima Graduate School, Tokushima (Japan)

7 More presentations in this session

Presentation thumbnail
Adiponectin forms a complex with electronegative L5 LDL in human plasma and inhibits its atherogenic effects
Professor T. Sawamura (Matsumoto, JP)
Abstract
Presentation thumbnail
Magnetic drug targeting to vascular injury regions and atherosclerotic lesions: in vivo pilot study
Doctor I. Cicha (Erlangen, DE)
Abstract
Presentation thumbnail
Nicotine promotes atherosclerosis development in apolipoprotein E-deficient mice through alpha 1 nicotinic acetylcholine receptor on RAW264.7 and MOVAS cells
Mr A. Ren (Shanghai, CN)
Presentation thumbnail
miR-147 deficiency in macrophages exacerbates atherosclerosis in mice
Mrs M. Nazari Jahantigh (Munich, DE)
Abstract
Presentation thumbnail
Deletion of cyclophilin d inhibits atherosclerotic plaque formation in apolipoprotein-e deficient mice
Doctor R. Umezu (Fukuoka, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Inflammation and microcirculation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources